Second‐generation antipsychotic drugs for major depressive disorder
References
Additional references
Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic‐induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry 1999;156(11):1686‐96.
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard I, Lewis G, Matthews K, McAllister‐Williams RH, Peveler RC, Scott J, Tylee A. Evidence‐based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 2008;Epub:1‐54.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III). Washington DC: American Psychiatric Association, 1980.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition‐ Revised (DSM‐III‐R). Washington, DC: American Psychiatric Association, 1987.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM‐IV). Washington DC: American Psychiatric Association, 1994.
Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 1998;18:63‐101.
Barbui C, Ciuna A, Nose M, Patten SB, Stegagno M, Burti L, Amaddeo F, Tansella M. Off‐label and non‐classical prescriptions of antipsychotic agents in ordinary in‐patient practice. Acta Psychiatrica Scandinavica 2004;109:275‐8.
Berger M. Psychische Erkrankungen. Klinik und Therapie. 2. München: Urban & Fischer, 2004.
Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
Cipriani A, Furukawa TA, Veronese A, Watanabe N, Churchill R, McGuire H, Barbui C. Paroxetine versus other anti‐depressive agents for depression. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006531]
Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second‐generation antipsychotics: a systematic review of one‐year studies. American Journal of Psychiatry 2004;161:414‐5.
Debattista C, Hawkins J. Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 2009;23(5):369‐77.
Der‐Simonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88.
Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623‐9.
Domino ME, Swartz MS. Who are the new users of antipsychotic medications. Psychiatric Services 2008;59:507‐14.
Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31:140‐9.
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing misssing standard deviations in meta‐analysis can provide accurate results. Journal of Clinical Epidemiology 2006;59:7‐10.
Gayetot D, Ansseau M, Triffaux JM. [When depression does not end. Resistant depression: recent clinical and therapeutic aspects]. Review Medical de Liege 2007;62(2):103‐11.
Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O´Keane V, Papakostas G, Vieta E, Zohar J. Advantages and disadvantages of combination treatment with antipsychotics: ECNP Consensus Meeting, March 2008, Nice. European Neuropsychopharmacology 2009;19:520‐32.
Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83.
Guy W. Clinical Global Impressions ‐ ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76‐338). Revised. Rockville MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH, 1976.
Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50‐5.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org2008.
Kawakami N. Epidemiology of depressive disorders in Japan and the world. Nippon Rinsho 2007;65(9):1578‐84.
Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382‐9.
Papakostas GI, Shelton RC, Smith J, Fava M. Augmentation of antidepressants with atypical antipsychotic medication for treatment‐resistant major depressive disorder: a meta‐analysis. Journal of Clinical Psychiatry 2007;68:826‐31.
Ravindran AV, Bradbury C, McKay M, da Silva TL. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders. Expert Opinion in Pharmacotherapy 2007;8(11):1693‐710.
Sajatovic M. Treatment for mood and anxiety disorders: quetiapine and aripiprazole. Current Psychiatry Reports 2003;5(4):320‐6.
Vital Signs. Seroquel led antipsychotics sales in 2006. Clinical Psychiatric News 2007;35:1.
World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD‐10). Geneva: World Health Organisation, 1992.
World Health Organisation. The European Health Report 2005. World Health Organisation, 2005.
Yatham LN, Goldstein JM, Vieta E, Bowden CL, Grunze H, Post RM, et al. Atypical antipsychotics in bipolar depression: potential mechanisms of action. Journal of Clinical Psychiatry 2005;66 (suppl 5):40‐8.
Zimmermann M, Posternak MA, Chelminski I. Derivation of a definition of remission on the Montgomery‐Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. Journal of Psychiatric Research 2004;38:577‐82.
